---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-047189"
form_type: "8-K/A"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T09:35:22.468002+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jazz Pharmaceuticals to acquire Chimerix for $8.55/share in all-cash tender offer

## Summary
- Tender offer to commence by March 24, 2025; Chimerix board unanimously recommends.
- Offer subject to minimum tender condition, HSR clearance, and no material adverse effect.
- After tender, merger under DGCL Section 251(h); remaining shares converted at same $8.55.
- Amendment No. 1 corrects typographical error in exhibit; no substantive changes to terms.

## SEC filing metadata
- accession: 0001193125-25-047189
- form_type: 8-K/A
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312525047189/0001193125-25-047189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312525047189/d844531d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-047189
- JSON: https://secwatch.observer/filing/0001193125-25-047189.json
- Plain text: https://secwatch.observer/filing/0001193125-25-047189.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.